SLC35G5
gene geneOn this page
Summary
SLC35G5 (solute carrier family 35 member G5, HGNC:15546) is a protein-coding gene on chromosome 8p23.1, encoding Solute carrier family 35 member G5 (Q96KT7).
This gene is intronless and probably arose from retrotransposition of a similar gene. It has high sequence similarity to the gene encoding acyl-malonyl condensing enzyme on chromosome 17.
Source: NCBI Gene 83650 — RefSeq curated summary.
At a glance
- GWAS associations: 16
- MANE Select transcript:
NM_054028
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15546 |
| Approved symbol | SLC35G5 |
| Name | solute carrier family 35 member G5 |
| Location | 8p23.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000177710 |
| Ensembl biotype | protein_coding |
| OMIM | 615199 |
| Entrez | 83650 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000382435
RefSeq mRNA: 1 — MANE Select: NM_054028
NM_054028
CCDS: CCDS5980
Canonical transcript exons
ENST00000382435 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001492046 | 11331012 | 11332360 |
Expression profiles
Bgee: expression breadth broad, 73 present calls, max score 59.23.
Top tissues by expression
99 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| granulocyte | CL:0000094 | 59.23 | gold quality |
| right testis | UBERON:0004534 | 51.29 | gold quality |
| left testis | UBERON:0004533 | 50.89 | gold quality |
| testis | UBERON:0000473 | 50.27 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 49.71 | gold quality |
| apex of heart | UBERON:0002098 | 48.75 | gold quality |
| blood | UBERON:0000178 | 48.22 | silver quality |
| mucosa of transverse colon | UBERON:0004991 | 46.80 | gold quality |
| spleen | UBERON:0002106 | 45.45 | gold quality |
| heart left ventricle | UBERON:0002084 | 44.08 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 43.64 | gold quality |
| right atrium auricular region | UBERON:0006631 | 43.31 | gold quality |
| prostate gland | UBERON:0002367 | 43.04 | gold quality |
| ganglionic eminence | UBERON:0004023 | 42.89 | silver quality |
| heart | UBERON:0000948 | 42.28 | gold quality |
| muscle tissue | UBERON:0002385 | 42.17 | silver quality |
| substantia nigra | UBERON:0002038 | 41.80 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 41.75 | silver quality |
| lymph node | UBERON:0000029 | 41.55 | gold quality |
| cortical plate | UBERON:0005343 | 40.98 | silver quality |
| pituitary gland | UBERON:0000007 | 40.81 | silver quality |
| endocervix | UBERON:0000458 | 40.44 | silver quality |
| hypothalamus | UBERON:0001898 | 40.20 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 40.16 | silver quality |
| stromal cell of endometrium | CL:0002255 | 39.85 | gold quality |
| colon | UBERON:0001155 | 39.84 | gold quality |
| adenohypophysis | UBERON:0002196 | 39.66 | silver quality |
| kidney | UBERON:0002113 | 39.60 | silver quality |
| ectocervix | UBERON:0012249 | 39.60 | silver quality |
| uterine cervix | UBERON:0000002 | 39.58 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.24 |
Regulation
Is transcription factor: no
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Slc35g3 | ENSMUSG00000018776 |
| rattus_norvegicus | Slc35g3 | ENSRNOG00000014519 |
| drosophila_melanogaster | CG5281 | FBGN0037902 |
Paralogs (5): SLC35G3 (ENSG00000164729), SLC35G2 (ENSG00000168917), SLC35G1 (ENSG00000176273), SLC35G4 (ENSG00000236396), SLC35G6 (ENSG00000259224)
Protein
Protein identifiers
Solute carrier family 35 member G5 — Q96KT7 (reviewed: Q96KT7)
Alternative names: Acyl-malonyl-condensing enzyme 1-like protein 2
All UniProt accessions (1): Q96KT7
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Tissue specificity. Expressed in placenta and testis.
Miscellaneous. The gene encoding this protein appears to have arisen by SVA-mediated retrotransposition of the SLC35G6 gene in the primate lineage.
Similarity. Belongs to the SLC35G solute transporter family.
RefSeq proteins (1): NP_473369* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000620 | EamA_dom | Domain |
| IPR037185 | EmrE-like | Homologous_superfamily |
Pfam: PF00892
UniProt features (15 total): transmembrane region 9, domain 2, sequence variant 2, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96KT7-F1 | 82.20 | 0.46 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 5 (showing top):
DESCARTES_FETAL_CEREBRUM_MEGAKARYOCYTES, WP_8P231_COPY_NUMBER_VARIATION_SYNDROME, GSE22601_DOUBLE_NEGATIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN, chr8p23, HNF4_Q6
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
332 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SLC35G5 | XKR6 | Q5GH73 | 572 |
| SLC35G5 | TTC39B | Q5VTQ0 | 445 |
| SLC35G5 | DEFB134 | Q4QY38 | 418 |
| SLC35G5 | SLC35E2A | P0CK97 | 398 |
| SLC35G5 | SLC35E2B | P0CK96 | 374 |
| SLC35G5 | MMAB | Q96EY8 | 353 |
| SLC35G5 | SLC25A52 | Q3SY17 | 349 |
| SLC35G5 | MTMR9 | Q96QG7 | 324 |
| SLC35G5 | FAM153A | Q9UHL3 | 324 |
| SLC35G5 | SLCO1B7 | G3V0H7 | 321 |
| SLC35G5 | PBX4 | Q9BYU1 | 311 |
| SLC35G5 | SLC22A24 | Q8N4F4 | 309 |
| SLC35G5 | SLC22A31 | A6NKX4 | 307 |
| SLC35G5 | NCAN | O14594 | 305 |
| SLC35G5 | TRIB1 | Q96RU8 | 305 |
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SLC35G5 | BCL2L13 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC35G5 | SLC35G6 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC35G5 | BCL2L13 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (5): SLC35G5 (Two-hybrid), SLC35G5 (Co-fractionation), CCPG1 (Affinity Capture-MS), SLC35F3 (Affinity Capture-MS), SLC35G6 (Affinity Capture-MS)
ESM2 similar proteins: A0A084AFH0, A1L3G4, A1Z7R6, A5WWC6, A7YW81, B0B8F4, B0K004, D3YVE8, O04508, O74750, O84584, P0C7Q5, P0C7Q6, P39542, P40004, P53403, Q00974, Q0Q7U7, Q0Q7U8, Q0Q7U9, Q0Q7V0, Q0V9U2, Q1PFJ4, Q23444, Q24JQ0, Q3UME2, Q5F297, Q5M7A3, Q5PT55, Q5ZJZ4, Q7RTP0, Q8BHK1, Q8MXJ9, Q8N808, Q94EI9, Q96KT7, Q9C508, Q9C654, Q9C8M1, Q9FG70
Diamond homologs: B0K004, D3YVE8, P0C7Q5, P0C7Q6, Q0Q7U7, Q0Q7U8, Q0Q7U9, Q0Q7V0, Q5F297, Q5M7A3, Q5ZJZ4, Q8N808, Q8TBE7, Q96KT7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
252 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 8:11331609:G:GT | donor_gain | 0.6400 |
| 8:11331857:C:CG | donor_gain | 0.6400 |
| 8:11331862:TTG:T | donor_gain | 0.6200 |
| 8:11331650:G:GT | donor_gain | 0.6100 |
| 8:11331464:A:AG | acceptor_gain | 0.5900 |
| 8:11331465:G:GG | acceptor_gain | 0.5900 |
| 8:11331857:C:G | donor_gain | 0.5800 |
| 8:11331103:A:T | donor_gain | 0.5600 |
| 8:11331081:G:GT | donor_gain | 0.5300 |
| 8:11331582:G:GA | donor_gain | 0.5300 |
| 8:11331574:C:G | donor_gain | 0.5200 |
| 8:11331658:CACAG:C | donor_loss | 0.5200 |
| 8:11331659:ACAGG:A | donor_loss | 0.5200 |
| 8:11331660:CAG:C | donor_loss | 0.5200 |
| 8:11331661:AGGTG:A | donor_loss | 0.5200 |
| 8:11331662:GGTGT:G | donor_loss | 0.5200 |
| 8:11331663:G:GG | donor_loss | 0.5200 |
| 8:11331664:T:A | donor_loss | 0.5200 |
| 8:11331651:A:T | donor_gain | 0.5100 |
| 8:11331681:GC:G | donor_gain | 0.5100 |
| 8:11331453:G:GT | donor_gain | 0.5000 |
| 8:11331701:G:GT | donor_gain | 0.5000 |
| 8:11331868:T:G | donor_gain | 0.5000 |
| 8:11331657:CCACA:C | donor_loss | 0.4900 |
| 8:11331769:A:AG | acceptor_gain | 0.4900 |
| 8:11331770:G:GG | acceptor_gain | 0.4900 |
| 8:11331654:G:T | donor_gain | 0.4800 |
| 8:11331682:C:G | donor_gain | 0.4800 |
| 8:11331860:A:AG | donor_gain | 0.4700 |
| 8:11331861:G:GG | donor_gain | 0.4700 |
AlphaMissense
2118 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 8:11331776:T:C | F224L | 0.904 |
| 8:11331778:C:A | F224L | 0.904 |
| 8:11331778:C:G | F224L | 0.904 |
| 8:11332061:A:C | S319R | 0.830 |
| 8:11332063:C:A | S319R | 0.830 |
| 8:11332063:C:G | S319R | 0.830 |
| 8:11331905:T:C | F267L | 0.787 |
| 8:11331907:C:A | F267L | 0.787 |
| 8:11331907:C:G | F267L | 0.787 |
| 8:11331599:A:C | S165R | 0.781 |
| 8:11331601:C:A | S165R | 0.781 |
| 8:11331601:C:G | S165R | 0.781 |
| 8:11331263:T:C | F53L | 0.778 |
| 8:11331265:C:A | F53L | 0.778 |
| 8:11331265:C:G | F53L | 0.778 |
| 8:11331749:T:C | F215L | 0.778 |
| 8:11331751:T:A | F215L | 0.778 |
| 8:11331751:T:G | F215L | 0.778 |
| 8:11331446:A:C | S114R | 0.716 |
| 8:11331448:C:A | S114R | 0.716 |
| 8:11331448:C:G | S114R | 0.716 |
| 8:11332040:G:A | G312R | 0.692 |
| 8:11332040:G:C | G312R | 0.692 |
| 8:11331821:T:C | F239L | 0.672 |
| 8:11331823:T:A | F239L | 0.672 |
| 8:11331823:T:G | F239L | 0.672 |
| 8:11332040:G:T | G312W | 0.639 |
| 8:11331608:G:A | G168R | 0.625 |
| 8:11331608:G:C | G168R | 0.625 |
| 8:11331511:A:C | K135N | 0.614 |
dbSNP variants (sampled 300 via entrez): RS1001286940 (8:11330883 C>A,G,T), RS1002317865 (8:11330168 C>A,T), RS1002438174 (8:11332786 G>A,T), RS1002691727 (8:11330034 G>A,C), RS1003040528 (8:11329026 T>C), RS1003092280 (8:11332761 G>A,T), RS1003351349 (8:11329623 T>G), RS1004128385 (8:11332210 ATAAT>A), RS1005109846 (8:11329064 T>A,C), RS1006153403 (8:11330679 G>A,T), RS1007124861 (8:11329676 C>A,T), RS1007155910 (8:11329766 T>C,G), RS1007994529 (8:11332296 T>C), RS1008025485 (8:11332441 T>G), RS1008617356 (8:11329176 A>G)
Disease associations
OMIM: gene MIM:615199 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
16 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000286_1 | Triglycerides | 3.000000e-08 |
| GCST003103_2 | Systemic lupus erythematosus | 8.000000e-06 |
| GCST010132_11 | Processed meat consumption | 4.000000e-10 |
| GCST010132_14 | Processed meat consumption | 2.000000e-15 |
| GCST010132_15 | Processed meat consumption | 1.000000e-09 |
| GCST010136_40 | Fruit consumption | 1.000000e-10 |
| GCST010136_5 | Fruit consumption | 9.000000e-09 |
| GCST010136_9 | Fruit consumption | 1.000000e-08 |
| GCST010142_4 | Fish- and plant-related diet | 2.000000e-12 |
| GCST010142_6 | Fish- and plant-related diet | 3.000000e-12 |
| GCST010142_63 | Fish- and plant-related diet | 2.000000e-12 |
| GCST010142_67 | Fish- and plant-related diet | 1.000000e-10 |
| GCST010142_70 | Fish- and plant-related diet | 8.000000e-10 |
| GCST010142_89 | Fish- and plant-related diet | 4.000000e-16 |
| GCST010142_90 | Fish- and plant-related diet | 7.000000e-15 |
| GCST010703_306 | Brain morphology (MOSTest) | 5.000000e-26 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004530 | triglyceride measurement |
| EFO:0008111 | diet measurement |
| EFO:0004346 | neuroimaging measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: transporter — SLC35 family of nucleotide sugar transporters
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| kojic acid | decreases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Endosulfan | increases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Tetrachlorodibenzodioxin | increases expression | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.